Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43. doi: 10.1164/rccm.201806-1160ST.
Right ventricular (RV) adaptation to acute and chronic pulmonary hypertensive syndromes is a significant determinant of short- and long-term outcomes. Although remarkable progress has been made in the understanding of RV function and failure since the meeting of the NIH Working Group on Cellular and Molecular Mechanisms of Right Heart Failure in 2005, significant gaps remain at many levels in the understanding of cellular and molecular mechanisms of RV responses to pressure and volume overload, in the validation of diagnostic modalities, and in the development of evidence-based therapies.
A multidisciplinary working group of 20 international experts from the American Thoracic Society Assemblies on Pulmonary Circulation and Critical Care, as well as external content experts, reviewed the literature, identified important knowledge gaps, and provided recommendations.
This document reviews the knowledge in the field of RV failure, identifies and prioritizes the most pertinent research gaps, and provides a prioritized pathway for addressing these preclinical and clinical questions. The group identified knowledge gaps and research opportunities in three major topic areas: 1) optimizing the methodology to assess RV function in acute and chronic conditions in preclinical models, human studies, and clinical trials; 2) analyzing advanced RV hemodynamic parameters at rest and in response to exercise; and 3) deciphering the underlying molecular and pathogenic mechanisms of RV function and failure in diverse pulmonary hypertension syndromes.
This statement provides a roadmap to further advance the state of knowledge, with the ultimate goal of developing RV-targeted therapies for patients with RV failure of any etiology.
右心室(RV)对急性和慢性肺动脉高压综合征的适应是短期和长期预后的重要决定因素。尽管自 2005 年 NIH 工作组就右心衰竭的细胞和分子机制举行会议以来,人们对 RV 功能和衰竭的理解取得了显著进展,但在理解 RV 对压力和容量超负荷的反应的细胞和分子机制、验证诊断方式以及开发循证治疗方面,仍存在许多层面的显著差距。
一个由 20 名国际专家组成的多学科工作组,来自美国胸科学会的肺循环和危重病学分会,以及外部内容专家,回顾了文献,确定了重要的知识差距,并提供了建议。
本文回顾了 RV 衰竭领域的知识,确定并优先考虑了最相关的研究空白,并为解决这些临床前和临床问题提供了一个优先途径。该小组在三个主要主题领域确定了知识差距和研究机会:1)优化方法,以评估临床前模型、人类研究和临床试验中急性和慢性疾病的 RV 功能;2)分析静息和运动时 RV 血流动力学的先进参数;3)阐明不同肺动脉高压综合征中 RV 功能和衰竭的潜在分子和发病机制。
本声明提供了进一步推进知识状态的路线图,最终目标是为任何病因导致 RV 衰竭的患者开发 RV 靶向治疗。